Cargando…

Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time

BACKGROUND: Aromatase inhibitors (AIs) are recommended as adjuvant treatment for estrogen-receptor positive breast carcinoma in postmenopausal women. Studies demonstrate mixed results as to the impact of AIs on cardiovascular (CV) events and overall survival. With the increasing number of pre- and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaaban, Adnan, Petersen, Ashley, Beckwith, Heather, Florea, Natalia, Potter, David A., Yee, Douglas, Vogel, Rachel I., Duprez, Daniel, Blaes, Anne H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104271/
https://www.ncbi.nlm.nih.gov/pubmed/37066265
http://dx.doi.org/10.21203/rs.3.rs-2758909/v1